Hansen Medical Announces FDA Clearance For CoHesionTM Module

Hansen Medical, Inc. (NASDAQ: HNSN), a developer of robotic technology for accurate 3D control of catheter movement during cardiac procedures, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the CoHesion? 3D Visualization Module for use in complex electrophysiology (EP) mapping procedures.

More: continued here

Filed under: Cardiovascular on July 4th, 2008